Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Brehony C, Trotter CL, Ramsay ME, Chandra M, Jolley KA, van der Ende A, Carion F, Berthelsen L, Hoffmann S, Harðardóttir H, Vazquez JA, Murphy K, Toropainen M, Caniça M, Ferreira E, Diggle M, Edwards GF, Taha MK, Stefanelli P, Kriz P, Gray SJ, Fox AJ, Jacobsson S, Claus H, Vogel U, Tzanakaki G, Heuberger S, Caugant DA, Frosch M, Maiden MC.

Clin Vaccine Immunol. 2014 Jun;21(6):847-53. doi: 10.1128/CVI.00133-14. Epub 2014 Apr 2.

2.

Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.

Bertrand S, Carion F, Wintjens R, Mathys V, Vanhoof R.

Antimicrob Agents Chemother. 2012 May;56(5):2268-72. doi: 10.1128/AAC.06310-11. Epub 2012 Jan 30.

3.

Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains.

Bertrand S, Van Meervenne E, De Baere T, Vanhoof R, Collard JM, Ruckly C, Taha M, Carion F.

Microbes Infect. 2011 Jul;13(7):684-90. doi: 10.1016/j.micinf.2011.02.006. Epub 2011 Mar 2.

PMID:
21376133
4.

Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Taha MK, Hedberg ST, Szatanik M, Hong E, Ruckly C, Abad R, Bertrand S, Carion F, Claus H, Corso A, Enríquez R, Heuberger S, Hryniewicz W, Jolley KA, Kriz P, Mollerach M, Musilek M, Neri A, Olcén P, Pana M, Skoczynska A, Sorhouet Pereira C, Stefanelli P, Tzanakaki G, Unemo M, Vázquez JA, Vogel U, Wasko I.

Antimicrob Agents Chemother. 2010 Sep;54(9):3651-8. doi: 10.1128/AAC.00315-10. Epub 2010 Jul 6.

5.

Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.

Taha MK, Vázquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, Cafferkey MT, Carion F, Christensen JJ, Diggle M, Edwards G, Enríquez R, Fazio C, Frosch M, Heuberger S, Hoffmann S, Jolley KA, Kadlubowski M, Kechrid A, Kesanopoulos K, Kriz P, Lambertsen L, Levenet I, Musilek M, Paragi M, Saguer A, Skoczynska A, Stefanelli P, Thulin S, Tzanakaki G, Unemo M, Vogel U, Zarantonelli ML.

Antimicrob Agents Chemother. 2007 Aug;51(8):2784-92. Epub 2007 May 21.

6.

New epidemiological features of meningococcal disease in Belgium.

Carion F, Van Looveren M, Goossens H.

Euro Surveill. 1997 Oct;2(10):80.

PMID:
12631800
7.

Surveillance of meningococcal infections in Belgium.

Van Looveren M, Carion F, Vandamme P, Goossens H.

Clin Microbiol Infect. 1998 Apr;4(4):224-228. No abstract available.

8.

Interpreting the rising incidence of meningococcal disease in Belgium: the contribution of molecular typing.

Van Looveren M, Caugant DA, Chapelle S, Carion F, Goossens H.

J Med Microbiol. 2001 Nov;50(11):986-90.

PMID:
11699596
9.

Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B.

Van Looveren M, Vandamme P, Hauchecorne M, Wijdooghe M, Carion F, Caugant DA, Goossens H.

J Clin Microbiol. 1998 Oct;36(10):2828-34.

Supplemental Content

Loading ...
Support Center